Delivery Order SPE2DB22D9353-SPE2DB25FX1TX
Award Date
3/25/25
Potential Completion Date
4/15/25
Potential Value
$70K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a delivery order under the Defense Logistics Agency's (DLA) SPE2DB indefinite delivery contract valued at up to $499,999,999. The contract is for the delivery of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical supplies, to support the recurring medical needs of military healthcare facilities worldwide. The specific product...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a firm fixed-price delivery order valued at $9,284.40. The contract was awarded by the Defense Logistics Agency (DLA) and has no set-aside designation. It is part of the DLA's larger SPE2DB Indefinite Delivery Contract (IDC) valued at up to $499,999,999, which allows the agency to issue delivery orders for a comprehensive range of pharmaceutical products to support the medical supply needs of...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a firm fixed-price delivery order valued at $7,737.00 for the supply of Xolair 150 mg/ml syringes. The award was made by the Defense Logistics Agency (DLA) under the Medical Supply Chain program, which facilitates the distribution of pharmaceutical products and medical supplies to Department of Defense (DoD) healthcare facilities worldwide. The contract has no set-aside designation and is part of a...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a Delivery Order (DO) valued at $37,137.60 with a firm fixed price pricing type. The award is under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) worth $499,999,999 and valid through November 2026. The contract is for the delivery of XOLAIR 150 MG/ML SYRINGEML, a specialized pharmaceutical product, to support the recurring medical supply...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a firm fixed-price delivery order with a value of $3,094.80. The award was made by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense, and supports the agency's Medical Supply Chain division. The contract is for the delivery of Xolair 150 mg/mL syringes, a specialized pharmaceutical product. This award is part of a larger indefinite delivery contract (IDC) with the DLA...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, was issued by the Defense Logistics Agency (DLA) under the Medical Supply Chain division. The $9,671.25 firm fixed-price delivery order is for the pharmaceutical product XOLAIR 150 MG/ML SYRINGEML, with a completion date of June 4, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the DLA to issue delivery...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a Delivery Order under the Defense Logistics Agency's (DLA) SPE2DB indefinite delivery contract (IDC). The IDC, valued up to $499,999,999, allows the DLA to issue firm fixed-price delivery orders for a wide range of pharmaceutical products to support the recurring medical supply needs of military health facilities worldwide. The specific award, valued at $9,284.40, is for the supply of XOLAIR 150 MG/ML...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a firm fixed-price delivery order worth $4,642.20 with the Defense Logistics Agency (DLA) under the Medical Supply Chain division. The award provides for the supply of XOLAIR 150 MG/ML syringe, a specialty medication, to support the recurring medical needs of military health facilities worldwide. The award is part of a larger $499,999,999 indefinite delivery contract (IDC)...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, was issued by the Defense Logistics Agency (DLA) under the SPE2DB program. The $9,284.40 firm fixed-price delivery order is for the supply of XOLAIR 150 MG/ML SYRINGEML, a pharmaceutical product, with an ultimate completion date of October 25, 2024. This award is part of a larger $499,999,999 indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, which allows the agency to...
This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award is a delivery order under a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that runs through December 31, 2025. This IDC allows the DLA to place firm fixed-price delivery orders with DMS Pharmaceutical Group for a comprehensive range of pharmaceutical items to support...